Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma

A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we focused on the infiltration and programmed death ligand 1 (PD-L1) expression of tumor-associated macrophages (TAMs) in the tumor microen...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong-Jun, Sung, Pil-Soo, Lee, Gil-Won, Cho, Sung-Woo, Kim, Sung-Min, Kang, Byung-Yoon, Hur, Won-Hee, Yang, Hyun, Lee, Soon-Kyu, Lee, Sung-Hak, Jung, Eun-Sun, Seo, Chang-Ho, Ahn, Joseph, Choi, Ho-Joong, You, Young-Kyoung, Jang, Jeong-Won, Bae, Si-Hyun, Choi, Jong-Young, Yoon, Seung-Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124544/
https://www.ncbi.nlm.nih.gov/pubmed/33946835
http://dx.doi.org/10.3390/ijms22094710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124544/
https://www.ncbi.nlm.nih.gov/pubmed/33946835
http://dx.doi.org/10.3390/ijms22094710

Ejemplares similares